Monomelic Amyotrophy

Monomelic amyotrophy (MMA), also known as Hirayama disease, Sobue disease, juvenile non-progressive amyotrophy and juvenile asymmetric segmental spinal muscular atrophy (JASSMA) — is an untreatable, focal motor neuron disease that primarily affects young (15–25 year old) males in India and Japan. MMA is marked by insidious onset of muscular atrophy, which stabilizes at a plateau after two to five years from which it neither improves nor worsens. There is no pain or sensory loss associated with MMA. Unlike other lower motor neuron diseases, MMA is not believed to be hereditary and fasciculations (involuntary muscle twitches) are rare.

EMG tests reveal loss of the nerve supply, or denervation, in the affected limb without conduction block (nerve blockage restricted to a small segment of the nerve). Increased sweating, coldness and cyanosis have been reported for a few patients, indicating involvement of the sympathetic nervous system.

While MMA will cause weakness and/or wasting in only one limb, EMG and NCV tests often show signs of reinnervation in the unaffected limbs.

Read more about Monomelic AmyotrophyTreatment, Prognosis, Epidemiology, Further Reading

Other articles related to "monomelic amyotrophy, monomelic":

Monomelic Amyotrophy - Further Reading
... "Benign monomelic amyotrophy of lower limb A rare entity with a characteristic muscular CT" ... "Benign monomelic amyotrophies of upper and lower limb are not associated to deletions of survival motor neuron gene" ... "Benign Monomelic Amyotrophy of the Lower Limb – Case Report and Brief Review of the Literature" ...